Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Value · Columbia Threadneedle

Multi-Manager Value Strategies Fund (CZMVX)

Ticker CZMVX · Since 2017-01-03 · · Holdings as of May 31, 2026

Expense ratio
0.69%$69/yr per $10k
5-yr return
+10.5%annualized
1-yr return
+12.9%as of Dec 2025
Net assets
$5.6Ball share classes
Holdings
324

Bottom line

Is CZMVX a good fund? The bottom line

CZMVX is a managed large value mutual fund from Columbia Threadneedle.

Its expense ratio is 0.69% — about $69 a year on every $10,000 invested, cheaper than 63% of large value funds we track.

It returned +12.9% over one year, +10.5% a year over five years, +11.1% a year over ten (as of Dec 31, 2025, per its prospectus).

With $5.6 billion in net assets and 324 holdings, its largest position is Columbia Short Term Cash Fund (2.6%) and the top 10 make up 18.9% of the portfolio.

What stands out

  • Broadly diversified (324 holdings)
  • No front-end sales load

Updated Nov 19, 2026

What CZMVX invests in

Multi-Manager Value Strategies Fund (the Fund) seeks to provide shareholders with growth of capital and income.

The Funds assets primarily are invested in equity securities. Equity securities generally include common stocks, but may also include preferred stocks and convertible securities. The Fund may invest in companies that have market capitalizations of any size. Under normal circumstances, the Fund invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in equity securities of value companies. The Fund considers value companies to be those companies that are either constituents of an index constructed by a third party to identify companies with various characteristics of value companies, or that have a higher book-to-price (B/P) ratio than the median ranked stock within the companys Global Industry Classification Standard (GICS) sector, have a higher EBITDA/EV (earnings before interest, taxes, depreciation and amortization-to-enterprise value) or…

From the fund's prospectus (filed Sep 24, 2026).

CZMVX performance

Fund calendar-year total returns, 2015–2025 2015: −3.7%; 2016: +17.2%; 2017: +19.7%; 2018: −9.0%; 2019: +28.6%; 2020: +5.8%; 2021: +25.6%; 2022: −8.0%; 2023: +11.8%; 2024: +12.9%; 2025: +12.9% −4% 2015 +17% 2016 +20% 2017 −9% 2018 +29% 2019 +6% 2020 +26% 2021 −8% 2022 +12% 2023 +13% 2024 +13% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
CZMVX+12.9%+10.5%+11.1%
Large Value median+13.6%+11.3%+10.2%

Source: Fund prospectus, as of Dec 31, 2025

Full CZMVX performance history →

What CZMVX costs

On a $10,000 investment, CZMVX's 0.69% expense ratio costs about $69 a year. The prospectus estimates $847 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.

See the full CZMVX fee table →

CZMVX top 10 holdings

#Holding% of fund
1Columbia Short Term Cash Fund2.56%
2Microsoft Corp2.35%
3JPMorgan Chase & Co2.12%
4Apple Inc1.81%
5Micron Technology Inc1.81%
6Amazon.com Inc1.80%
7ConocoPhillips1.73%
8Abbott Laboratories1.72%
9Union Pacific Corp1.51%
10Berkshire Hathaway Inc1.49%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 18.9% of the fund. See all top 25 holdings and asset mix →

Alternatives to CZMVX

More funds like CZMVX →

CZMVX FAQ

What is the expense ratio of CZMVX?
CZMVX's expense ratio is 0.69%, which works out to about $69 a year for every $10,000 invested. The prospectus estimates total costs of $847 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is CZMVX a good investment?
It depends on your goals, but the data points to: broadly diversified (324 holdings); no front-end sales load. This is general information, not personalized advice.
What does CZMVX hold?
CZMVX's largest holdings are Columbia Short Term Cash Fund (2.6%), Microsoft Corp (2.3%), JPMorgan Chase & Co (2.1%), Apple Inc (1.8%), Micron Technology Inc (1.8%). It holds 324 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is CZMVX's 5-year return?
CZMVX returned +10.5% a year over the five years ending Dec 31, 2025, and +11.1% a year over ten years. Past performance does not guarantee future results.
Does CZMVX have a sales load?
No. CZMVX has no front-end sales charge.
Who manages CZMVX?
CZMVX is offered by Columbia Threadneedle through Columbia Funds Series Trust II.